Annovis BioInc Working Capital vs. Z Score

ANVS
 Stock
  

USD 12.35  0.15  1.20%   

For Annovis BioInc profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Annovis BioInc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Annovis BioInc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Annovis BioInc's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Annovis BioInc over time as well as its relative position and ranking within its peers. Please continue to Trending Equities.
  
Is Annovis BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis BioInc. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
102 M
Return On Assets
(0.44) 
Return On Equity
(0.74) 
The market value of Annovis BioInc is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis BioInc's value that differs from its market value or its book value, called intrinsic value, which is Annovis BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis BioInc's market value can be influenced by many factors that don't directly affect Annovis BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine Annovis BioInc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Annovis BioInc Z Score vs. Working Capital Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Annovis BioInc's current stock value. Our valuation model uses many indicators to compare Annovis BioInc value to that of its competitors to determine the firm's financial worth.
Annovis BioInc is rated fourth in working capital category among related companies. It is rated fourth in z score category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Annovis BioInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Annovis BioInc's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Annovis BioInc's earnings, one of the primary drivers of an investment's value.

Annovis Z Score vs. Working Capital

Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Annovis BioInc 
Working Capital 
 = 
Current Assets 
Current Liabilities 
770 K
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Annovis BioInc 
Z Score 
 = 
Sum Of  
 
5 Factors 
-8.9
To calculate Z-Score one would need to know current working capital of the company, its total assets, and liabilities, amount of latest retained earnings as well as earnings before interest and tax. Z-Score can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area' with scores of less than 1, indicating the high probability of distress. Z Score is used widely by financial auditors, accountants, money managers, loan processers, wealth advisers, as well as day traders. In the last 25 years, many financial models that utilize z score has been proved to be successful as a predictor of corporate bankruptcy.

Annovis Z Score Comparison

Annovis BioInc is currently under evaluation in z score category among related companies.

Annovis BioInc Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Annovis BioInc, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Annovis BioInc will eventually generate negative long term returns. The profitability progress is the general direction of Annovis BioInc's change in net profit over the period of time. It can combine multiple indicators of Annovis BioInc, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania. Annovis Bio operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 3 people.

Annovis Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Annovis BioInc. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Annovis BioInc position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Annovis BioInc's important profitability drivers and their relationship over time.

Use Annovis BioInc in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Annovis BioInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis BioInc will appreciate offsetting losses from the drop in the long position's value.

Annovis BioInc Pair Trading

Annovis BioInc Pair Trading Analysis

The ability to find closely correlated positions to Annovis BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Annovis BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Annovis BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Annovis BioInc to buy it.
The correlation of Annovis BioInc is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Annovis BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Annovis BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Annovis BioInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Annovis BioInc position

In addition to having Annovis BioInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Healthcare Thematic Idea Now

Healthcare
Healthcare Theme
Companies that provide healthcare goods and services including hospitals, health maintenance organizations, HMOs, or medical aid manufacturers. The Healthcare theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Trending Equities. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for analysis

When running Annovis BioInc price analysis, check to measure Annovis BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis BioInc is operating at the current time. Most of Annovis BioInc's value examination focuses on studying past and present price action to predict the probability of Annovis BioInc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Annovis BioInc's price. Additionally, you may evaluate how the addition of Annovis BioInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
To fully project Annovis BioInc's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Annovis BioInc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Annovis BioInc's income statement, its balance sheet, and the statement of cash flows.
Potential Annovis BioInc investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Annovis BioInc investors may work on each financial statement separately, they are all related. The changes in Annovis BioInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Annovis BioInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.